Do cardiac risk factors affect the homocysteine and asymmetric dimethylarginine relationship in patients with coronary artery diseases?

Department of Biochemistry, Ege University, Faculty of Medicine, Izmir, Turkey.
Clinical biochemistry (Impact Factor: 2.28). 06/2012; 45(16-17). DOI: 10.1016/j.clinbiochem.2012.06.024
Source: PubMed


Elevated homocysteine (Hcy) concentrations have been shown to be a risk factor for atherosclerotic vascular disease and thrombosis. Increased asymmetric dimethylarginine (ADMA) levels have been implicated in the pathogenesis of numerous conditions affecting the cardiovascular system. In this study, the influence of cardiovascular risk factors and other variables on Hcy and ADMA relationship in patients with coronary artery disease (CAD) was investigated.

Design and methods:
Seventy-five patients with CAD were divided into three tertiles according to their Hcy levels. The effect of age, gender, blood pressure, lipid profile, renal function, and the presence of diabetes, insulin resistance, heart failure, inflammation, overweight, smoking and severity of coronary atherosclerosis on Hcy and ADMA relationship was evaluated.

ADMA concentrations of patients in the middle and highest Hcy tertiles were significantly higher than the patients in the lowest tertile. When ADMA concentrations were adjusted for demographic, clinical and laboratory variables, the significant differences in ADMA concentrations between the tertiles were preserved. ADMA levels positively correlated with Hcy. Homocysteine levels positively correlated with serum creatinine and NT-proBNP concentrations and negatively correlated with glomerular filtration rates. Stepwise multiple regression analysis revealed Hcy as the unique predictor of ADMA levels.

Homocysteine concentration has an effect on ADMA levels. There is a strong correlation between Hcy and ADMA. Cardiovascular risk factors do not have an influence on this relationship.

Download full-text


Available from: Burcu Barutcuoglu
  • Source
    • "First, our group had previously described independent and additive effects of a hyperinsulinemic euglycemic clamp-derived index of IR and an increased ADMA to L-arginine ratio, but not ADMA, on the number of major coronary vessels with >50% narrowings in 53 patients with stable angina and pre-diabetes [35]. Second, Isiklar et al. [41] have recently observed the lack of correlation between ADMA and Gensini score in 75 stable angina subjects, including 17 type 2 diabetics. Nevertheless, ADMA was unrelated to the degree of IR in the both cited studies [35,41]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthesis inhibitor, and insulin resistance (IR) have been implicated in atherogenesis. Our aim was to estimate relations between ADMA, the magnitude of IR and angiographic indices of extent and severity of coronary atherosclerosis in non-diabetic men with stable coronary artery disease (CAD). We studied 151 non-diabetic men (mean age 57 +/- 11 years) with stable angina, obstructive CAD (at least 1 luminal diameter stenosis of >=70% in major coronary segments) and without heart failure, and 34 age-matched controls free of >=50% coronary narrowings. The following CAD indices were computed: the number of major epicardial vessels with >=70% stenosis, Sullivan extent score representing a proportion of the visible coronary tree with vessel wall irregularities, and Gensini score which reflects both CAD severity and extent, yet assigning a heavier weight to proximal segments and to the more severe narrowings by a non-linear point system. An estimate of IR was derived by homeostasis model assessment (HOMA-IR) from fasting insulin and glucose. Among the CAD patients, the proportions of subjects with 1-vessel, 2- vessel and 3-vessel CAD were 26%, 25% and 49%, respectively. ADMA levels were higher in patients with obstructive CAD compared to the controls (0.51 +/- 0.10 vs. 0.46 +/- 0.09 mumol/L [SD], P = 0.01), whereas HOMA-IR was similar (median, 3.2 [interquartile range: 2.4--4.9] vs. 2.9 [2.3--4.7], P = 0.2). Within the CAD group, ADMA increased across ascending quartiles of Sullivan score (Spearman's rho = 0.23, P = 0.004), but not with Gensini score (rho = 0.12, P = 0.15) or the number of vessels involved (rho = 0.08, P = 0.3). ADMA correlated to log-transformed Sullivan score (r = 0.21, P = 0.008), which was only slightly attenuated upon multivariate adjustment (beta = 0.19 +/- 0.08 [SEM], P = 0.015). HOMA-IR did not differ according to any measure of angiographic CAD (P >= 0.2). ADMA and log(HOMA-IR) were mutually unrelated (r = 0.07, P = 0.4). ADMA is associated with diffuse but not focal coronary atherosclerosis in non-diabetic men with stable CAD irrespectively of the degree of IR. The independent relationship between ADMA and coronary atherosclerotic burden may contribute to the well-recognized prognostic effect of ADMA in CAD.
    Full-text · Article · Oct 2013 · Cardiovascular Diabetology
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background/Aims: Homocysteine-induced endothelial dysfunction favors the development of cardiovascular diseases through accumulation of endogenous nitric oxide (NO) synthase (NOS) inhibitor asymmetric dimethylarginine (ADMA). Dimethylarginine dimethylaminohydrolase 2 (DDAH2) is the major enzyme for the degradation of ADMA in endothelial cells. The purpose of this study was to determine whether suppressed DDAH2 expression contributed to impairments of DDAH/ADMA/NOS/NO pathway induced by homocysteine in endothelial cells and whether DDAH2 overexpression could prevent endothelial cell dysfunction caused by homocysteine. Methods: Liposome-mediated transfection of endothelial cells was performed to establish the cell line of DDAH2 overexpression. After treatment of cells with 1 mmol/L homocysteine for 24 h, the transcription and expression of DDAH1 and DDAH2, DDAH and NOS activities as well as ADMA and NO concentrations were measured. Results : Treatment of endothelial cells with homocysteine significantly suppressed the transcription and expression of DDAH2 but not DDAH1. This suppression was associated with the declined DDAH activity, increased ADMA accumulation, inhibited NOS activity and decreased NO production in endothelial cells. DDAH2 overexpression not only resisted homocysteine-induced decline of DDAH activity, but also decreased the accumulation of endogenous ADMA, subsequently attenuated the reductions of NOS activity and NO production induced by homocysteine. Conclusions: These results indicate that suppression of DDAH2 expression is a culprit for homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells, and therapeutic manipulation of DDAH2 expression may be a promising strategy for preventing endothelial dysfunction and cardiovascular diseases associated with hyperhomocysteinemia.
    No preview · Article · Nov 2012 · Cellular Physiology and Biochemistry
  • [Show abstract] [Hide abstract]
    ABSTRACT: Homocystinuria is a neurometabolic disease caused by a severe deficiency of cystathionine beta-synthase activity, resulting in severe hyperhomocysteinemia. Affected patients present several symptoms including a variable degree of motor dysfunction. In this study, we investigated the effect of chronic hyperhomocysteinemia on the cell viability of the mitochondrion, as well as on some parameters of energy metabolism, such as glucose oxidation and activities of pyruvate kinase, citrate synthase, isocitrate dehydrogenase, malate dehydrogenase, respiratory chain complexes and creatine kinase in gastrocnemius rat skeletal muscle. We also evaluated the effect of creatine on biochemical alterations elicited by hyperhomocysteinemia. Wistar rats received daily subcutaneous injections of homocysteine (0.3-0.6 µmol/g body weight) and/or creatine (50 mg/kg body weight) from the 6th to the 28th days of age. The animals were decapitated 12 h after the last injection. Homocysteine decreased the cell viability of the mitochondrion and the activities of pyruvate kinase and creatine kinase. Succinate dehydrogenase was increased other evaluated parameters were not changed by this amino acid. Creatine, when combined with homocysteine, prevented or caused a synergistic effect on some changes provoked by this amino acid. Creatine per se or creatine plus homocysteine altered glucose oxidation. These findings provide insights into the mechanisms by which homocysteine exerts its effects on skeletal muscle function, more studies are needed to elucidate them. Although creatine prevents some alterations caused by homocysteine, it should be used with caution, mainly in healthy individuals because it could change the homeostasis of normal physiological functions. Copyright © 2012 John Wiley & Sons, Ltd.
    No preview · Article · Dec 2012 · Cell Biochemistry and Function
Show more